Registration Dossier

Diss Factsheets

Toxicological information


Currently viewing:

Administrative data

Description of key information

Waiving of study: In accordance with column 2 of REACH Annex X, a carcinogenicity study (required in section 8.9.1) does not need to be conducted as FeNaEDDHA is not classified as mutagen category 3. There is no evidence from the repeated dose studies that the substance is able to induce hyperplasia and/or pre-neoplastic lesions.

Key value for chemical safety assessment

Justification for classification or non-classification

Based on the the provisions laid down in Regulation (EC) No 1272/2008 as amended for the ninth time in Regulation (EC) No 2016/1179, the substance is not considered to be classified for carcinogenicity.

Additional information